Exergen Grows Globally to Over 60 Countries and Expands Regulatory Approval in 2024

February 06, 2025 01:00 AM AEDT | By EIN Presswire
 Exergen Grows Globally to Over 60 Countries and Expands Regulatory Approval in 2024
Image source: EIN Presswire
WATERTOWN, MA, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- Watertown, Mass, February 5, 2025 – Exergen Corporation, the global leader in non-invasive temperature measurement technologies, is rapidly expanding its international presence. In 2024 Exergen successfully entered several new and strategically important markets, including Mexico, Columbia, and Indonesia. In addition, the company is strengthening its cooperation with OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) partners across China, Europe, and the United States.

Exergen’s rapid expansion into new international markets underscores its dedication to making high-quality, non-invasive temperature measurement accessible to people across the globe. It expects to reach 100 countries in 2025 and secure regulatory approval in key markets including Saudi Arabia, South Korea, and the UAE - changing the way the world takes temperature within 3 years.

Global Expansion and Regulatory Approval

In 2024, Exergen increased its OEM/ODM footprint from 50 to over 60 countries and opened its new European office and fulfillment center in Eindhoven, The Netherlands. With the world increasingly focused on health and safety, Exergen strengthened its global presence by securing regulatory approval in seven additional countries, including Brazil, Columbia, Costa Rica, India, Indonesia, Panama, and Peru.

In addition, Exergen hosted its first International Distributors Event that introduced Exergen’s strategic direction, product development initiatives, and the competitive advantages essential for transforming global temperature-taking practices. Attendees from over 25 countries gained valuable insights into market competition, effective strategies, and networking opportunities.

"As the demand for reliable, accurate, and user-friendly thermometers continues to grow worldwide, Exergen is committed to ensuring that individuals and healthcare professionals have access to the most advanced temperature measurement technology," said Dr. Francesco Pompei, Founder and CEO of Exergen Corporation. "We are proud to expand our global footprint and give healthcare providers access to our advanced Temporal Artery Thermometers they need to improve health outcomes. Our growth with standalone and connected Temporal Artery Thermometers reveals the depth of our expansion and positions us as a strong international leader.”

Exergen's Temporal Artery Thermometers (TAT) include:

— TAT-5000S: Tailored for large hospitals dealing with substantial patient volumes, this model is a standalone, highly accurate, and non-invasive thermometer. The Connected version of the TAT-5000S seamlessly integrates into renowned spot monitors like Philips SureSigns VS4, GE Healthcare VC*150, V100, Mindray Accutorr 7 Series and VS-900 Series, Corometric, Midmark IQvitals Zone, and others, facilitating streamlined operations in hectic medical environments.
— TAT-2000: This durable professional lite thermometer expedites temperature measurements by doctors and nurses in small clinics and school systems, enhancing healthcare productivity. Backed by a 7-year warranty, the TAT-2000 is a testament to Exergen’s commitment to quality and reliability.
— TAT-2000C: A consumer-focused model employing the same advanced technology as its professional counterparts, offering advanced capabilities at an accessible price point.

To learn more about our full line of Temporal Artery Thermometers reach out to us here or at an industry event.

About Exergen

Exergen Corporation, the leader in non-invasive temperature measurement technologies for industrial and medical applications, delivers non-invasive temperature meters with higher accuracy, lower costs, less process control, and higher reliability than previously possible. Known in both healthcare and consumer markets for its award-winning arterial thermometer, Exergen was founded by MIT and Harvard – educated and Harvard researcher Dr. Francesco Pompei, who holds more than 100 patents supporting Exergen products. Exergen Corporation is headquartered in Watertown, Massachusetts, United States.

EXERGEN P/N 850377, Rev 1

Christina Guilbert
Exergen
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.